Roche Holding (RHHBY) EBITDA US GAAP (year values) |
|||||||||
2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
EBITDA, ₣ | ? | 21 739 000 000 | 22 501 000 000 | 22 862 000 000 | 21 526 000 000 | 18 657 000 000 | 30 282 000 000 | ||
Changes by years, y/y, % | +20% | +4% | +2% | -6% | -13% | +0.5% |
Roche Holding. EBITDA US GAAP, ₣
Roche Holding. EBITDA US GAAP, changes, %
Roche Holding. EBITDA US GAAP, sum by quarters, ₣
Roche Holding (RHHBY) EBITDA US GAAP (quarter values) |
||||||||
2022Q4 | 2023Q1 | 2023Q2 | 2023Q3 | 2023Q4 | LTM ? | |||
EBITDA, ₣ | ? | 9 824 000 000 | 6 120 500 000 | 11 207 000 000 | 4 338 500 000 | 8 616 000 000 | 30 282 000 000 | |
Changes by years, y/y, % | -20% | -12% | ||||||
Changes by quarters, q/q, % | +82% | -38% | +83% | -61% | +99% |